Delineation of 12-Lead ECG Representative Beats Using Convolutional Encoder–Decoders with Residual and Recurrent Connections
Sensors · 2024
DOI: 10.3390/s24144645 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2024. Verfasst von Vessela Krasteva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str. Bl. 105, 1113 Sofia, Bulgaria. Hauptthemen laut MEDLINE: Electrocardiography, Neural Networks, Computer, Algorithms, Signal Processing, Computer-Assisted. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Science Fund, Bulgarian National Science Fund.
Abstract (Originalsprache)
The aim of this study is to address the challenge of 12-lead ECG delineation by different encoder–decoder architectures of deep neural networks (DNNs). This study compares four concepts for encoder–decoders based on a fully convolutional architecture (CED-Net) and its modifications with a recurrent layer (CED-LSTM-Net), residual connections between symmetrical encoder and decoder feature maps (CED-U-Net), and sequential residual blocks (CED-Res-Net). All DNNs transform 12-lead representative beats to three diagnostic ECG intervals (P-wave, QRS-complex, QT-interval) used for the global delineation of the representative beat (P-onset, P-offset, QRS-onset, QRS-offset, T-offset). All DNNs were trained and optimized using the large PhysioNet ECG database (PTB-XL) under identical conditions, applying an advanced approach for machine-based supervised learning with a reference algorithm for ECG delineation (ETM, Schiller AG, Baar, Switzerland). The test results indicate that all DNN architectures are equally capable of reproducing the reference delineation algorithm’s measurements in the diagnostic PTB database with an average P-wave detection accuracy (96.6%) and time and duration errors: mean values (−2.6 to 2.4 ms) and standard deviations (2.9 to 11.4 ms). The validation according to the standard-based evaluation practices of diagnostic electrocardiographs with the CSE database outlines a CED-Net model, which measures P-duration (2.6 ± 11.0 ms), PQ-interval (0.9 ± 5.8 ms), QRS-duration (−2.4 ± 5.4 ms), and QT-interval (−0.7 ± 10.3 ms), which meet all standard tolerances. Noise tests with high-frequency, low-frequency, and power-line frequency noise (50/60 Hz) confirm that CED-Net, CED-Res-Net, and CED-LSTM-Net are robust to all types of noise, mostly presenting a mean duration error < 2.5 ms when compared to measurements without noise. Reduced noise immunity is observed for the U-net architecture. Comparative analysis with other published studies scores this research within the lower range of time errors, highlighting its competitive performance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, Acad. G. Bonchev Str. Bl. 105, 1113 Sofia, Bulgaria.
- Signal Processing, Schiller AG, Altgasse 68, CH-6341 Baar, Switzerland.
ORCID-Profile: Vessela Krasteva, Ramun Schmid, Irena Jekova
Förderung
- Bulgarian Science Fund
- Bulgarian National Science Fund
Zitieren
APA
Krasteva, V., Stoyanov, T., Schmid, R., & Jekova, I. (2024). Delineation of 12-Lead ECG Representative Beats Using Convolutional Encoder–Decoders with Residual and Recurrent Connections. Sensors. https://doi.org/10.3390/s24144645
Vancouver
Krasteva V, Stoyanov T, Schmid R, Jekova I. Delineation of 12-Lead ECG Representative Beats Using Convolutional Encoder–Decoders with Residual and Recurrent Connections. Sensors. 2024. doi:10.3390/s24144645
BibTeX
@article{Krasteva2024,
author = {Krasteva, Vessela and Stoyanov, Todor and Schmid, Ramun and Jekova, Irena},
title = {Delineation of 12-Lead ECG Representative Beats Using Convolutional Encoder–Decoders with Residual and Recurrent Connections},
journal = {Sensors},
year = {2024},
doi = {10.3390/s24144645}
}
EUVIMED